Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis
暂无分享,去创建一个
M. Matsushita | Y. Tomino | S. Horikoshi | I. Ohsawa | S. Nagamachi | H. Inoshita | H. Ohi | G. Kusaba | M. Ishii | N. Sato | H. Ohi | S. Horikoshi | A. Toki | Seiji Nagamachi | Masaya Ishii | Gaku Kusaba
[1] T. Rabelink,et al. Urinary properdin excretion is associated with intrarenal complement activation and poor renal function. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] Y. Tomino,et al. Type B insulin resistance syndrome with systemic lupus erythematosus. , 2010, Clinical nephrology.
[3] D. Hourcade,et al. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis , 2008, Proceedings of the National Academy of Sciences.
[4] L. Trouw,et al. Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation12 , 2008, The Journal of Immunology.
[5] M. Harboe,et al. The alternative complement pathway revisited , 2008, Journal of cellular and molecular medicine.
[6] D. Hourcade,et al. Properdin Can Initiate Complement Activation by Binding Specific Target Surfaces and Providing a Platform for De Novo Convertase Assembly1 , 2007, The Journal of Immunology.
[7] D. Hourcade. The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement* , 2006, Journal of Biological Chemistry.
[8] M. Daha,et al. Role of complement in innate and autoimmunity. , 2005, Journal of nephrology.
[9] S. Thiel,et al. Collections and ficolins: humoral lectins of the innate immune defense. , 2003, Annual review of immunology.
[10] V. Fadok,et al. Apoptosis: giving phosphatidylserine recognition an assist – with a twist , 2003, Current Biology.
[11] T. Chan,et al. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinura. , 2002, Kidney international.
[12] T. Fujita,et al. Activation of the Lectin Complement Pathway by H-Ficolin (Hakata Antigen)1 , 2002, The Journal of Immunology.
[13] S. Thiel,et al. The mannan-binding lectin pathway of complement activation: biology and disease association. , 2001, Molecular immunology.
[14] T. Fujita,et al. Cutting Edge: Complement-Activating Complex of Ficolin and Mannose-Binding Lectin-Associated Serine Protease1 , 2000, The Journal of Immunology.
[15] H. Colten,et al. Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B1 , 2000, The Journal of Immunology.
[16] M. Nangaku,et al. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. , 1999, Journal of the American Society of Nephrology : JASN.
[17] R. Würzner,et al. Glomerular deposition of mannose-binding lectin in human glomerulonephritis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[18] T. Fujita,et al. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[20] K. Harris,et al. The role of proteinuria in the progression of chronic renal failure. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] T. Fujita,et al. A Novel Human Serum Lectin with Collagen- and Fibrinogen-like Domains That Functions as an Opsonin (*) , 1996, The Journal of Biological Chemistry.
[22] T. Fujita,et al. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation. , 1995, Immunobiology.
[23] T. Fujita,et al. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. , 1994, International immunology.
[24] T. Fujita,et al. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease , 1992, The Journal of experimental medicine.
[25] J. Volanakis,et al. Radioassays for quantitation of intact complement proteins C2 and B in human serum. , 1988, Journal of immunological methods.
[26] A. J. Mcadams,et al. Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis. , 1979, Kidney international.
[27] J. Minta,et al. Glomerular and dermal depostion of properdin in systemic lupus erythematosus. , 1972, The New England journal of medicine.
[28] H. Müller-Eberhard,et al. Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults. , 1967, Journal of immunology.
[29] Min Chen,et al. Differential Deposition of C4d and MBL in Glomeruli of Patients with ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis , 2009, Journal of Clinical Immunology.
[30] P. Lachmann. The amplification loop of the complement pathways. , 2009, Advances in immunology.
[31] M. Nangaku. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. , 2004, Internal medicine.